Светлый фон

Dresler, M., Koch, S. P., Wehrle, R., Spoormaker, V. I., Holsboer, F., Steiger, A., Sämann, P. G., Obrig, H., Czisch, M., ‘Dreamed movement elicits activation in the sensorimotor cortex’, Curr Biol, 8 November 2011, 21(21): 1833—7.

Curr Biol

van der Helm, E., Yao, J., Dutt, S., Rao, V., Saletin, J. M., Walker, M. P., ‘REM sleep depotentiates amygdala activity to previous emotional experiences’, Curr Biol, 6 December 2011, 21(23): 2029—32.

Curr Biol

 

14. Бессонница

14. Бессонница

Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., Takano, T., Deane, R., Nedergaard, M., ‘Sleep drives metabolite clearance from the adult brain’, Science, 19 October 2013, 342(6156): 373—7.

Science

Fernandez-Mendoza, J., Shea, S., Vgontzas, A. N., Calhoun, S. L., Liao, D., Bixler, E. O., ‘Insomnia and incident depression: role of objective sleep duration and natural history’, J Sleep Res, August 2015, 24(4): 390—98.

J Sleep Res

Li, Y., Vgontzas, A. N., Fernandez-Mendoza, J., Bixler, E. O., Sun, Y., Zhou, J., Ren, R., Li, T., Tang, X., ‘Insomnia with physiological hyperarousal is associated with hypertension’, Hypertension, March 2015, 65(3): 644—50.

Hypertension

Vgontzas, A. N., Fernandez-Mendoza, J., Liao, D., Bixler, E. O., ‘Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder’, Sleep Med Rev, August 2013, 17(4): 241—54.

Sleep Med Rev

Mitchell, M. D., Gehrman, P., Perlis, M., Umscheid, C. A., ‘Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review’, BMC Fam Pract, 25 May 2012, 13: 40.

BMC Fam Pract

Jarrin, D. C., Alvaro, P. K., Bouchard, M. A., Jarrin, S. D., Drake, C. L., Morin, C. M., ‘Insomnia and hypertension: A systematic review’, Sleep Med Rev., 16 February 2018. pii: S1087—0792(17)30051—5.

Sleep Med Rev

Penninkilampi, R., Eslick, G. D., ‘A Systematic Review and Meta-Analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias’, CNS Drugs, 20 June 2018. doi: 10.1007/s40263—018—0535—3.